Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SCHIZOPHRENIA DRUG NONCOMPLIANCE MAY LEAD TO ONE-THIRD OF HOSPITAL COSTS

Executive Summary

SCHIZOPHRENIA DRUG NONCOMPLIANCE MAY LEAD TO ONE-THIRD OF HOSPITAL COSTS during short stays associated with the disease, Peter Weiden, MD, St. Lukes-Roosevelt Hospital Center, suggested Nov. 7 at an American Medical Association Science Reporters Conference in Seattle. Weiden and Mark Olsson, MD, Columbia University, looked at the effect on readmission rates of drug discontinuation after discharge and found that relapse rates among schizophrenics following hospitalization increased from 3.5% to 12% per month after patients stopped their medication.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS025369

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel